Germany At Home Testing Kits Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Germany At Home Testing Kits Market Analysis

  • Healthcare
  • Published Report
  • May 2023
  • Country Level
  • 350 Pages
  • No of Tables: 25
  • No of Figures: 41

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GERMANY AT-HOME TESTING KITS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE

2.8 MARKET POSITION COVERAGE GRID

2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.1 DBMR MARKET POSITION GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

4.3 STRATEGIC INITIATIVES

4.4 BRAND ANALYSIS

4.5 PRICING ANALYSIS

5 GERMANY AT-HOME TESTING KITS MARKET: REGULATIONS

5.1 REGULATION IN EUROPE

5.2 GUIDELINES FOR TESTING KITS

6 GERMANY AT-HOME TESTING KITS MARKET, MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISE IN THE ADOPTION OF AT-HOME TESTING KITS DUE TO THE INCREASE IN THE PREVALENCE OF HEALTH DISORDERS

6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES AND ONLINE STORES

6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF STD DIAGNOSIS

6.1.4 LOW COST AND EASE TO USE AT-HOME TEST KITS

6.2 RESTRAINTS

6.2.1 PRODUCT RECALL OF AT-HOME TESTING KITS

6.2.2 INACCURACY OF RESULTS BY SELF-TESTING KITS

6.2.3 STRINGENT GOVERNMENT REGULATIONS FOR THE MANUFACTURING AND DISTRIBUTION OF TESTING KITS

6.3 OPPORTUNITIES

6.3.1 EXPANDING BUSINESS THROUGH SUBSIDIARIES

6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS

6.4 CHALLENGES

6.4.1 LOW AWARENESS IN SOCIETY

6.4.2 REDUCTION IN THE R&D BUDGET

7 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE

7.1 OVERVIEW

7.2 HEALTH

7.2.1 DIABETES KITS

7.2.2 KIDNEY FUNCTION TEST KITS

7.2.3 LIVER FUNCTION TEST KITS

7.2.4 PROTEIN KITS

7.2.5 IRON STATUS KITS

7.2.6 HEART DISEASE RISK TEST KITS

7.2.7 THYROID FUNCTION

7.2.8 RED BLOOD CELLS

7.2.9 WHITE BLOOD CELLS

7.2.10 CLOTTING STATUS

7.2.11 HORMONE

7.2.12 PSA

7.2.13 MENOPAUSE TEST

7.2.14 ANXIETY

7.2.15 ASTHMA

7.2.16 ATRIAL FIBRILLATION

7.2.17 GOUT

7.2.18 HDL AND LDL CHOLESTROL TEST KITS

7.2.19 HIGH BLOOD PRESSURE

7.2.20 OTHERS

7.3 BEAUTY AND WELLNESS

7.3.1 SKIN MICROBIME TEST

7.3.2 GENETIC BASED TEST KITS

7.3.3 FOOD SENSITIVITY TEST KITS

7.3.4 SEX HORMONE

7.3.4.1 FEMALE HORMONE TEST

7.3.4.2 MALE HORMONE TEST

7.3.5 HAIR, NAILS AND SKIN TEST KITS

7.3.6 STRESS TEST KITS

7.3.7 ALCOHOL FLUSH REACTION

7.3.8 CAFFEINE CONSUMPTION

7.3.9 DEEP SLEEP

7.3.10 MUSCLE COMPOSITION

7.3.11 SATURATED FAT

7.3.12 SLEEP MOVEMENT

7.3.13 ALLERGY TESTING

7.3.14 INTOLERANCE TESTING

7.3.14.1 LACTOSE INTOLERANCE

7.3.14.2 VEGAN INTOLERANCE TESTING

7.3.14.3 OTHER TEST

7.3.15 GUT MICROBIOME TEST

7.3.16 SKIN DNA TEST

7.4 STD TEST

7.4.1 HIV TEST

7.4.2 GONORRHEA TEST

7.4.3 SYPHILIS TEST

7.4.4 HERPES TEST

7.4.5 TRICHOMONIASIS

7.4.6 HEPATITIS B

7.4.7 HEPATITIS C

7.4.8 MEASLES

7.4.9 RUBELLA

7.4.10 VARICELLA

7.4.11 CHLAMYDIA TEST

7.4.12 OTHERS

7.5 NUTRITION

7.5.1 VITAMINS

7.5.1.1 D3

7.5.1.2 B12

7.5.1.3 ACTIVE B12

7.5.2 VITALITY

7.5.2.1 HEALTH MARKERS

7.5.2.2 IRON STATUS

7.5.2.3 MINERALS

7.5.3 OMEGA 3 TEST

7.5.4 IODINE DEFICIENCY TEST

7.5.5 ZINC TEST

7.5.6 SELENIUM TEST

7.5.7 MAGNESIUM BLOOD TEST

7.5.8 FERRITIN TEST

7.5.9 AMINO ACID TEST

7.6 PREGNANCY TEST

7.6.1 STRIP TESTS

7.6.2 MIDSTREAM TEST

7.6.3 CASSETTE TEST

7.6.4 DIGITAL TEST

7.6.5 HCG URINE TEST

7.6.6 HCG BLOOD TEST

7.6.7 LH URINE TEST

7.6.8 FSH URINE TEST

7.7 DRUG ABUSE TEST KITS

7.7.1 MARUUANA KITS

7.7.2 OPIATES KITS

7.7.3 ALCOHOL KITS

7.7.4 OTHERS

7.8 OVULATION PREDICTOR TEST KIT

7.9 OTHERS TEST TYPES

7.9.1 MALE INFERTILITY TEST TYPE

7.9.2 URINARY TRACT INFECTIONS TEST

7.9.3 MENOPAUSE TEST KITS

7.9.4 FECAL OCCULT BLOOD TEST

7.9.5 OTHERS

8 GERMANY AT-HOME TESTING KITS MARKET, BY TYPE

8.1 OVERVIEW

8.2 STRIP

8.2.1 RETAIL PHARMACIES

8.2.2 ONLINE PHARMACIES

8.2.3 DRUG STORE

8.2.4 SUPERMARKET/HYPERMARKET

8.2.5 CASSETTES

8.2.6 RETAIL PHARMACIES

8.2.7 ONLINE PHARMACIES

8.2.8 DRUG STORE

8.2.9 SUPERMARKET/HYPERMARKET

8.2.10 MIDSTREAM

8.2.11 RETAIL PHARMACIES

8.2.12 ONLINE PHARMACIES

8.2.13 DRUG STORE

8.2.14 SUPERMARKET/HYPERMARKET

8.2.15 DIP CARD

8.2.16 RETAIL PHARMACIES

8.2.17 ONLINE PHARMACIES

8.2.18 DRUG STORE

8.2.19 SUPERMARKET/HYPERMARKET

8.2.20 TEST PANEL

8.2.21 RETAIL PHARMACIES

8.2.22 ONLINE PHARMACIES

8.2.23 DRUG STORE

8.2.24 SUPERMARKET/HYPERMARKET

8.3 OTHERS

9 GERMANY AT-HOME TESTING KITS MARKET, BY AGE

9.1 OVERVIEW

9.2 ADULT

9.3 GERIATRIC

9.4 PEDIATRIC

10 GERMANY AT-HOME TESTING KITS MARKET, BY USAGE

10.1 OVERVIEW

10.2 DISPOSABLE

10.3 REUSABLE

11 GERMANY AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE

11.1 OVERVIEW

11.2 BLOOD

11.3 SALIVA

11.4 URINE

11.5 OTHER SAMPLE TYPES

12 GERMANY AT-HOME TESTING KITS MARKET, BY INCOME

12.1 OVERVIEW

12.2 MIDDLE INCOME

12.3 LOW INCOME

12.4 HIGH INCOME

13 GERMANY AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 RETAIL PHARMACIES

13.3 ONLINE PHARMACIES

13.4 DRUG STORE

13.5 SUPERMARKET/HYPERMARKET

14 GERMANY AT-HOME TESTING KITS MARKET, COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 ABBOTT

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUS ANALYSIS

16.1.3 PRODUCT PORTFOLIO

16.1.4 RECENT DEVELOPMENTS

16.2 F. HOFFMANN- LA ROCHE LTD

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 PRODUCT PORTFOLIO

16.2.4 RECENT DEVELOPMENT

16.3 SIEMENS HEALTHCARE GMBH

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 PRODUCT PORTFOLIO

16.3.4 RECENT DEVELOPMENTS

16.4 QUIDEL CORPORATION.

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 PRODUCT PORTFOLIO

16.4.4 RECENT DEVELOPMENT

16.5 CARDINAL HEALTH.

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENTS

16.6 ASCENSIA DIABETES CARE HOLDINGS AG.

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 B. BRAUN SE MELSUNGEN AG

16.7.1 COMPANY SNAPSHOT

16.7.2 REVENUE ANALYSIS

16.7.3 PRODUCT PORTFOLIO

16.7.4 RECENT DEVELOPMENTS

16.8 BIOLYTICAL LABORATORIES INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 BTNX INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 CARE DIAGNOSTICA

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 DEXCOM, INC.

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 PRODUCT PORTFOLIO

16.11.4 RECENT DEVELOPMENTS

16.12 DRÄGERWERK AG & CO. KGAA

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 JOHNSON & JOHNSON SERVICES, INC.

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 PRODUCT PORTFOLIO

16.13.4 RECENT DEVELOPMENTS

16.14 KIWENO GMBH

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 MP BIOMEDICALS.

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENTS

16.16 NOVA BIOMEDICAL

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENT

16.17 PIRAMAL ENTERPRISES LTD.

16.17.1 COMPANY SNAPSHOT

16.17.2 REVENUE ANALYSIS

16.17.3 PRODUCT PORTFOLIO

16.17.4 RECENT DEVELOPMENTS

16.18 PRIMA LAB SA

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 SELFDIAGNOSTICS OU

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 SA SCIENTIFIC LTD.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 PRICES OF PRODUCTS OFFERED BY SOME OF THE COMPANIES:

TABLE 2 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 3 GERMANY HEALTH IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 4 GERMANY BEAUTY AND WELLNESS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 5 GERMANY SEX HORMONE IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 6 GERMANY INTOLERANCE TESTING IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 7 GERMANY STD TEST IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 8 GERMANY NUTRITION IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 9 GERMANY VITAMINS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 10 GERMANY VITALITY IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 11 GERMANY PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY PRODUCT, 2021-2030 (USD MILLION), 2021-2030 (USD MILLION)

TABLE 12 GERMANY PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 13 GERMANY DRUG ABUSE TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 14 GERMANY OTHER TEST TYPE IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 15 GERMANY AT-HOME TESTING KITS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 16 GERMANY STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 17 GERMANY CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 18 GERMANY MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 19 GERMANY MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 20 GERMANY MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 21 GERMANY AT-HOME TESTING KITS MARKET, BY AGE, 2021-2030 (USD MILLION)

TABLE 22 GERMANY AT-HOME TESTING KITS MARKET, BY USAGE, 2021-2030 (USD MILLION)

TABLE 23 GERMANY AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)

TABLE 24 GERMANY AT-HOME TESTING KITS MARKET, BY INCOME, 2021-2030 (USD MILLION)

TABLE 25 GERMANY AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

List of Figure

FIGURE 1 GERMANY AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 2 GERMANY AT-HOME TESTING KITS MARKET: DATA TRIANGULATION

FIGURE 3 GERMANY AT-HOME TESTING KITS MARKET: DROC ANALYSIS

FIGURE 4 GERMANY AT-HOME TESTING KITS MARKET: GERMANY VS REGIONAL MARKET ANALYSIS

FIGURE 5 GERMANY AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GERMANY AT-HOME TESTING KITS MARKET: MARKET POSITION COVERAGE GRID

FIGURE 7 GERMANY AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GERMANY AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GERMANY AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 10 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES AND ONLINE STORES IS EXPECTED TO DRIVE GERMANY AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 11 HEALTH SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE IN 2023 & 2030

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GERMANY AT HOME TESTING KITS MARKET

FIGURE 13 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022

FIGURE 14 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)

FIGURE 15 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2023-2030)

FIGURE 16 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 17 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, 2022

FIGURE 18 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, 2021-2030 (USD MILLION)

FIGURE 19 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, CAGR (2023-2030)

FIGURE 20 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 21 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, 2022

FIGURE 22 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, 2023-2030 (USD MILLION)

FIGURE 23 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2023-2030)

FIGURE 24 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE

FIGURE 25 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, 2022

FIGURE 26 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, 2023-2030 (USD MILLION)

FIGURE 27 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, CAGR (2023-2030)

FIGURE 28 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, LIFELINE CURVE

FIGURE 29 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2022

FIGURE 30 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2021-2030 (USD MILLION)

FIGURE 31 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, CAGR (2023-2030)

FIGURE 32 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, LIFELINE CURVE

FIGURE 33 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, 2022

FIGURE 34 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, 2021-2030 (USD MILLION)

FIGURE 35 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, CAGR (2023-2030)

FIGURE 36 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, LIFELINE CURVE

FIGURE 37 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 38 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 39 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 40 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 41 GERMANY AT-HOME TESTING KITS MARKET: COMPANY SHARE 2022 (%)

Frequently Asked Questions

The Germany At-Home Testing Kits Market is projected to grow at a CAGR of 10.5% during the forecast period by 2030.
The major players in the Germany At-Home Testing Kits Market are Abbott, Siemens Healthcare GmbH, F. Hoffman- La Roche Ltd, Quidel Corporation, Cardinal Health, bioLytical Laboratories Inc., kiweno GmbH, Nova Biomedical, Johnson & Johnson Services, Inc., etc.
The Germany At-Home Testing Kits Market is segmented on the basis of test type, type, income, age, sample type, usage, and distribution channels.
Various factors can cause false results, such as manufacturing defects, low feasibility, incorrect instructions, or misinterpreting results